We use cookies for a better user experience. Read our Privacy Policy

I Agree

Healthcare Contract Research Outsourcing Market

Healthcare Contract Research Outsourcing Market (Service: Clinical Trial Service, Regulatory Services, Clinical Data Management & Biometrics, Medical Writing, Pharmacovigilance, Site Management Protocol, and Others; Therapeutic Area: Oncology/Hematology, CNS, CV/Metabolic, Respiratory, Infectious Diseases, Immunology, Rare Diseases, Medical Devices, and Others; and End-user: Pharmaceutical Companies, Biotechnology Companies, Medical Device Companies, and Academic Institutes & Government Organizations) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028

Healthcare Contract Research Outsourcing Market Outlook 2028

  • The global healthcare contract research outsourcing market was valued at US$ 38.04 Bn in 2020
  • It is estimated to expand at a CAGR of 6.6% from 2021 to 2028
  • The global healthcare contract research outsourcing market is expected to reach the value of US$ 63.09 Bn by the end of 2028

Analysts’ Viewpoint on Healthcare Contract Research Outsourcing Market Scenario

The healthcare contract research outsourcing market is projected to witness strong growth during the forecast period driven by increase in funding for small to mid-sized pharmaceutical, biotechnology, and medical device companies, thus driving the companies to opt for CRO services with focus on niche markets. The global healthcare contract research outsourcing market is witnessing high growth, owing to globalization of clinical trials, increasing efforts for optimization of costs and development time for drug development, and rise in varied services and solutions offered by the CROs. Increased access to specialized technologies and therapeutics expertise is projected to fuel the adoption of clinical trial services in the North America during the forecast period.

Incremental Opportunities for Healthcare Contract Research Outsourcing Market Players

The global healthcare contract research outsourcing market is expected to expand on the back of several factors including surge in efforts intended for costs & drug development time optimization, increase in different services and solutions provided by the CROs, and globalization of clinical trials. Some of the important services available in the healthcare contract research outsourcing market include regulatory service, clinical trial service, pharmacovigilance, site management protocol, and medical writing. These services are mainly used by biotechnology companies, pharmaceutical companies, academic institutes & government organizations, and medical device companies across the globe.

Enterprises from the global healthcare contract research outsourcing market are estimated to observe increase in demand for regulatory services outsourcing. This increase can be attributed to rise in scrutiny by regulatory authorities, including the EMA and FDA at all stages of clinical trials. Moreover, changing regulatory needs in each region is expected to drive the demand opportunities for regulatory services outsourcing activities.

Request a sample to get extensive insights into the Healthcare Contract Research Outsourcing Market

Expansion of Companies to Gain Potential Revenue Benefits Boosts Market Growth

Companies in the healthcare contract research outsourcing market are entering into collaboration and acquisition agreements in order to maintain their leading market position and expand their presence in newer regions. Some of the key players operating in the global healthcare contract research outsourcing market are focusing on offering quality services to gain attention from consumers. Outsourcing improves the global reach with respect to drug development with minimum maintenance cost, as CROs are well-versed with regulatory requirements of various regions to fueling the expansion of healthcare contract research outsourcing market. Healthcare companies often outsource drug development functions to contract research organizations to efficiently and effectively use the development capabilities internationally.

To understand how our report can bring difference to your business strategy, Ask for a brochure

North America Dominates Global Healthcare Contract Research Outsourcing Market

North America is expected to offer lucrative opportunities due to factors such as presence of advanced infrastructure required for clinical researches and key government incentive programs in the region, specifically in the U.S. In addition, increase in availability of therapeutics expertise and specialized technologies is expected to result in rise in the number of clinical trial services in the U.S. in the upcoming years. The North America healthcare contract research outsourcing market is rising with increasing complex regulatory process & growing regulatory burden. The market in North America is primarily driven by advanced infrastructure of clinical research sites, and effective government incentive programs in United States. The Asia Pacific region is projected to be fastest growing region in the global healthcare contract research outsourcing market during the forecast period. In Asia Pacific, China and India are significant markets for healthcare CRO and India is estimated to grow at a rapid pace during the forecast period.

Stuck in a neck-to-neck competition with other brands? Request a custom report on Healthcare Contract Research Outsourcing Market

CROs to Contribute to Success of Pharmaceutical Industry

The clinical, therapeutic, and regulatory expertise of CROs help to improve the complete cost of development and accelerate time to market a new product. CROs have become larger and enormously more diversified across various therapeutic areas and functions, expanding their penetration. Small pharmaceutical companies are also looking for advancements in product development through CRO services due to rise in demand for innovative products and patent expiration. CROs are anticipated to expand geographically and add competencies in emerging therapeutic areas, while boosting their current services beyond traditional clinical capabilities, including post-approval, commercial, informatics, etc. where low - outsourced penetration observed, further enhancing the demand for CROs, driving greater outsourcing demand. The regulatory services outsourcing is anticipated to increase due to increased scrutiny by regulatory bodies such as the FDA and EMA at every stage of clinical trial and changing regulatory requirements as per the region.

Healthcare Contract Research Outsourcing Market: Overview

  • Healthcare companies often outsource drug development functions to contract research organizations to efficiently and effectively use the development capabilities internationally
  • The clinical, therapeutic, and regulatory expertise of CROs helps to improve the complete cost of development and accelerate time to market for a new product
  • CROs have become larger and more diversified across various therapeutic areas and functions, expanding their penetration
  • The global healthcare contract research outsourcing market has been segmented based on service, therapeutic area, and end-user
  • The global healthcare contract research outsourcing market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global healthcare contract research outsourcing market in terms of revenue in 2020 and the trend is projected to continue during the forecast period.

Late Stage Drug Development Outsourcing: Key Driver

  • Transit of a drug from the laboratory to market is a time consuming process, with regulatory authorities demanding for more trial data evidences. Late stage development process demands large number of patient recruitment and longer trials. Hence, most of the development activities are outsourced to CROs.
  • For instance, in June 2018, Laboratory Corporation of America Holdings acquired Sciformix Corporation (a U.S.-based scientific process outsourcing firm that lays emphasis on pharmacovigilance and regulatory solutions for biopharmaceutical and medical devices companies) in order to strengthen its position in the later phases of drug and device development, especially for post-marketing pharmacovigilance and market access solutions. Sciformix is a part of Covance (LabCorp’s drug development business), which will support Covance’s work in transforming drug development through innovation and high efficiency.
  • Healthcare companies are seeking approvals of multiple regions simultaneously. Global CROs are well-positioned to provide late-stage development services with an added expertise of regulatory knowledge of various geographies, which drives the demand for their services.

Oncology/Hematology Segment to Dominate Global Market

  • A robust pipeline of more than 600 molecules for oncology is undergoing late-stage development. Hence, the oncology/hematology segment is anticipated to capture the largest market share by the end of the forecast period.
  • In 2021, the Food and Drug Administration (FDA) approved 50 new drugs for 22 indications, but there are still a lot more incurable cancer types
  • This increases the need of development of new drug products, driving the drug development. Moreover, competition in the oncology segment is high, as no single therapy is sufficient for the treatment of cancer. This calls for continuous development of better treatment options, which fuels the oncology segment.

North America to Dominate Healthcare Contract Research Outsourcing Market

  • In terms of region, the global healthcare contract research outsourcing market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
  • North America is projected to account for the largest share of 43.10% of the global market by 2028. The market in the region is likely to reach US$ 27.19 Bn by 2028, expanding at a CAGR of 5.6% from 2021 to 2028

Major Players

  • Key players operating in the global healthcare contract research outsourcing market include
    • Syneos Health
    • PAREXEL International
    • ICON plc
    • PRA Health Sciences, Inc.
    • Charles River
    • Laboratory Corporation of America Holdings (Covance)
    • IQVIA
    • Medpace
    • Pharmaceutical Product Development, LLC.
  • Each of these players has been profiled in the healthcare contract research outsourcing market report based on parameters such as company overview, financial overview, business strategies, application portfolio, business segments, and recent developments

Healthcare Contract Research Outsourcing Market Snapshot

Attribute

Detail

Market Size Value in 2020 (Base Year)

US$ 38.04 Bn

Market Forecast Value in 2028

US$ 63.09 Bn

Growth Rate (CAGR)

6.6%

Forecast Period

2021–2028

Quantitative Units

US$ Mn for Value

Market Analysis

It includes cross segment analysis at regional level. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, pricing analysis, and parent industry overview.

Format

Electronic (PDF)

Market Segmentation

  • Service
    • Clinical Trial Service
      • Preclinical
      • Clinical
    • Regulatory Service
    • Clinical Data Management & Biometrics
      • Electronic Data Capture
      • Electronic Patient Recorded Outcomes
      • Others
    • Medical Writing
    • Pharmacovigilance
    • Site Management Protocol
    • Others
  • Therapeutic Area
    • Oncology / Hematology
    • CNS
    • CV / Metabolic
    • Respiratory
    • Infectious Diseases
    • Immunology
    • Rare Diseases
    • Medical Devices
    • Others
  • End-user
    • Pharmaceutical Companies
    • Biotechnology Companies
    • Medical Device Companies
    • Academic Institutes & Government Organizations

Regions Covered

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest of Europe
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Rest of Asia Pacific
  • Brazil
  • Mexico
  • Rest of Latin America
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Companies Profiled

  • Syneos Health
  • PAREXEL International
  • ICON plc
  • PRA Health Sciences, Inc.
  • Charles River
  • Laboratory Corporation of America Holdings (Covance)
  • IQVIA
  • Medpace
  • Pharmaceutical Product Development, LLC.

Customization Scope

Available upon request

Pricing

Available upon request

Healthcare Contract Research Outsourcing Market – Segmentation

TMR’s study on the global healthcare contract research outsourcing market includes information divided into four segments: service, therapeutic area, end-user, and region. Changing industry trends and other market dynamics associated with these segments of the global healthcare contract research outsourcing market are discussed in detail.

Service
  • Clinical Trial Services
  • Regulatory Services
  • Clinical Data Management & Biometrics
  • Medical Writing
  • Pharmacovigilance
  • Site Management Protocol
  • Others
Therapeutic Area
  • Oncology / Hematology
  • CNS
  • CV / Metabolic
  • Respiratory
  • Infectious Diseases
  • Immunology
  • Rare Diseases
  • Medical Devices
  • Others
End-User
  • Pharmaceutical Companies
  • Biotechnology Companies
  • Medical Device Companies
  • Academic Institutes & Government Organizations
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Interested in this report?
Get a FREE sample now!

Get Free Sample

*Get Sample Report (PDF) sent to your email within minutes

Frequently Asked Questions

What is the total market worth of healthcare contract research outsourcing market?

Healthcare contract research outsourcing market to surpass the value of US$ 63.09 by 2028

What is the anticipated CAGR of the healthcare contract research outsourcing market in the forecast period?

Healthcare contract research outsourcing market is projected to witness CAGR of over 6.6% from 2021 to 2028

What are the key driving factors for the growth of the healthcare contract research outsourcing market?

Healthcare contract research outsourcing market is driven by increase in different services and solutions provided by the CROs

Which region is expected to project the highest market share in the global healthcare contract research outsourcing market?

Asia Pacific region is projected to be fastest growing region in global healthcare contract research outsourcing market during the forecast period

Who are the key players in the global healthcare contract research outsourcing market?

Key players in the global healthcare contract research outsourcing market include Syneos Health, IQVIA, PRA Health Sciences, Inc., ICON PLC, and Laboratory Corporation of America Holdings

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Healthcare Contract Research Outsourcing Market

4. Market Overview

    4.1. Introduction

        4.1.1. Service Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Healthcare Contract Research Outsourcing Market Analysis and Forecast, 2017–2028

        4.4.1. Market Revenue Projections (US$ Mn)

        4.4.2. Market Volume/Unit Shipments Projections

    4.5. Porter’s Five Force Analysis

5. Key Insights

    5.1. Key Mergers & Acquisitions

    5.2. Regulatory Scenario by Region/globally

    5.3. COVID-19 Impact Analysis

6. Global Healthcare Contract Research Outsourcing Market Analysis and Forecast, by Service

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value & Volume Forecast, by Service, 2017–2028

        6.3.1. Clinical Trial Services

        6.3.2. Regulatory Services

        6.3.3. Clinical Data Management & Biometrics

        6.3.4. Medical Writing

        6.3.5. Pharmacovigilance

        6.3.6. Site Management Protocol

        6.3.7. Others

    6.4. Market Attractiveness Analysis, by Service

7. Global Healthcare Contract Research Outsourcing Market Analysis and Forecast, by End-user  

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value & Volume Forecast, by End-user, 2017–2028

        7.3.1. Pharmaceutical Companies

        7.3.2. Biotechnology Companies

        7.3.3. Medical Devices

        7.3.4. Academic Institutes & Government Organizations

    7.4. Market Attractiveness Analysis, by End-user  

8. Global Healthcare Contract Research Outsourcing Market Analysis and Forecast, by Therapeutic Area

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Market Value & Volume Forecast, by Therapeutic Area, 2017–2028

        8.3.1. Oncology/Hematology

        8.3.2. CNS

        8.3.3. CV/Metabolic

        8.3.4. Respiratory

        8.3.5. Infectious Diseases

        8.3.6. Immunology

        8.3.7. Rare Diseases

        8.3.8. Medical Devices

        8.3.9. Others

    8.4. Market Attractiveness Analysis, by Therapeutic Area

9. Global Healthcare Contract Research Outsourcing Market Analysis and Forecast, by Region

    9.1. Key Findings

    9.2. Market Value & Volume Forecast, by Region

        9.2.1. North America

        9.2.2. Europe

        9.2.3. Asia Pacific

        9.2.4. Latin America

        9.2.5. Middle East & Africa

    9.3. Market Attractiveness Analysis, by Region

10. North America Healthcare Contract Research Outsourcing Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Market Value & Volume Forecast, by Service, 2017–2028

        10.2.1. Clinical Trial Services

        10.2.2. Regulatory Services

        10.2.3. Clinical Data Management & Biometrics

        10.2.4. Medical Writing

        10.2.5. Pharmacovigilance

        10.2.6. Site Management Protocol

        10.2.7. Others

    10.3. Market Value & Volume Forecast, by End-user, 2017–2028

        10.3.1. Pharmaceutical Companies

        10.3.2. Biotechnology Companies

        10.3.3. Medical Devices

        10.3.4. Academic Institutes & Government Organizations

    10.4. Market Value & Volume Forecast, by Therapeutic Area, 2017–2028

        10.4.1. Oncology/Hematology

        10.4.2. CNS

        10.4.3. CV/Metabolic

        10.4.4. Respiratory

        10.4.5. Infectious Diseases

        10.4.6. Immunology

        10.4.7. Rare Diseases

        10.4.8. Medical Devices

        10.4.9. Others

    10.5. Market Value & Volume Forecast, by Country, 2017–2028

        10.5.1. U.S.

        10.5.2. Canada

    10.6. Market Attractiveness Analysis

        10.6.1. By Service

        10.6.2. By End-user  

        10.6.3. By Therapeutic Area

        10.6.4. By Country

11. Europe Healthcare Contract Research Outsourcing Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value & Volume Forecast, by Service, 2017–2028

        11.2.1. Clinical Trial Services

        11.2.2. Regulatory Services

        11.2.3. Clinical Data Management & Biometrics

        11.2.4. Medical Writing

        11.2.5. Pharmacovigilance

        11.2.6. Site Management Protocol

        11.2.7. Others

    11.3. Market Value & Volume Forecast, by End-user, 2017–2028

        11.3.1. Pharmaceutical Companies

        11.3.2. Biotechnology Companies

        11.3.3. Medical Devices

        11.3.4. Academic Institutes & Government Organizations

    11.4. Market Value & Volume Forecast, by Therapeutic Area, 2017–2028

        11.4.1. Oncology/Hematology

        11.4.2. CNS

        11.4.3. CV/Metabolic

        11.4.4. Respiratory

        11.4.5. Infectious Diseases

        11.4.6. Immunology

        11.4.7. Rare Diseases

        11.4.8. Medical Devices

        11.4.9. Others

    11.5. Market Value & Volume Forecast, by Country/Sub-region, 2017–2028

        11.5.1. Germany

        11.5.2. U.K.

        11.5.3. France

        11.5.4. Spain

        11.5.5. Italy

        11.5.6. Rest of Europe

    11.6. Market Attractiveness Analysis

        11.6.1. By Service

        11.6.2. By End-user  

        11.6.3. By Therapeutic Area

        11.6.4. By Country/Sub-region

12. Asia Pacific Healthcare Contract Research Outsourcing Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value & Volume Forecast, by Service, 2017–2028

        12.2.1. Clinical Trial Services

        12.2.2. Regulatory Services

        12.2.3. Clinical Data Management & Biometrics

        12.2.4. Medical Writing

        12.2.5. Pharmacovigilance

        12.2.6. Site Management Protocol

        12.2.7. Others

    12.3. Market Value & Volume Forecast, by End-user, 2017–2028

        12.3.1. Pharmaceutical Companies

        12.3.2. Biotechnology Companies

        12.3.3. Medical Devices

        12.3.4. Academic Institutes & Government Organizations

    12.4. Market Value & Volume Forecast, by Therapeutic Area, 2017–2028

        12.4.1. Oncology/Hematology

        12.4.2. CNS

        12.4.3. CV/Metabolic

        12.4.4. Respiratory

        12.4.5. Infectious Diseases

        12.4.6. Immunology

        12.4.7. Rare Diseases

        12.4.8. Medical Devices

        12.4.9. Others

    12.5. Market Value & Volume Forecast, by Country/Sub-region, 2017–2028

        12.5.1. China

        12.5.2. Japan

        12.5.3. India

        12.5.4. Australia & New Zealand

        12.5.5. Rest of Asia Pacific

    12.6. Market Attractiveness Analysis

        12.6.1. By Service

        12.6.2. By End-user  

        12.6.3. By Therapeutic Area

        12.6.4. By Country/Sub-region

13. Latin America Healthcare Contract Research Outsourcing Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value & Volume Forecast, by Service, 2017–2028

        13.2.1. Clinical Trial Services

        13.2.2. Regulatory Services

        13.2.3. Clinical Data Management & Biometrics

        13.2.4. Medical Writing

        13.2.5. Pharmacovigilance

        13.2.6. Site Management Protocol

        13.2.7. Others

    13.3. Market Value & Volume Forecast, by End-user, 2017–2028

        13.3.1. Pharmaceutical Companies

        13.3.2. Biotechnology Companies

        13.3.3. Medical Devices

        13.3.4. Academic Institutes & Government Organizations

    13.4. Market Value & Volume Forecast, by Therapeutic Area, 2017–2028

        13.4.1. Oncology/Hematology

        13.4.2. CNS

        13.4.3. CV/Metabolic

        13.4.4. Respiratory

        13.4.5. Infectious Diseases

        13.4.6. Immunology

        13.4.7. Rare Diseases

        13.4.8. Medical Devices

        13.4.9. Others

    13.5. Market Value & Volume Forecast, by Country/Sub-region, 2017–2028

        13.5.1. Brazil

        13.5.2. Mexico

        13.5.3. Rest of Latin America

    13.6. Market Attractiveness Analysis

        13.6.1. By Service

        13.6.2. By End-user  

        13.6.3. By Therapeutic Area

        13.6.4. By Country/Sub-region

14. Middle East & Africa Healthcare Contract Research Outsourcing Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Market Value & Volume Forecast, by Service, 2017–2028

        14.2.1. Clinical Trial Services

        14.2.2. Regulatory Services

        14.2.3. Clinical Data Management & Biometrics

        14.2.4. Medical Writing

        14.2.5. Pharmacovigilance

        14.2.6. Site Management Protocol

        14.2.7. Others

    14.3. Market Value & Volume Forecast, by End-user, 2017–2028

        14.3.1. Pharmaceutical Companies

        14.3.2. Biotechnology Companies

        14.3.3. Medical Devices

        14.3.4. Academic Institutes & Government Organizations

    14.4. Market Value & Volume Forecast, by Therapeutic Area, 2017–2028

        14.4.1. Oncology/Hematology

        14.4.2. CNS

        14.4.3. CV/Metabolic

        14.4.4. Respiratory

        14.4.5. Infectious Diseases

        14.4.6. Immunology

        14.4.7. Rare Diseases

        14.4.8. Medical Devices

        14.4.9. Others

    14.5. Market Value & Volume Forecast, by Country/Sub-region, 2017–2028

        14.5.1. GCC Countries

        14.5.2. South Africa

        14.5.3. Rest of Middle East & Africa

    14.6. Market Attractiveness Analysis

        14.6.1. By Service

        14.6.2. By End-user  

        14.6.3. By Therapeutic Area

        14.6.4. By Country/Sub-region

15. Competition Landscape

    15.1. Market Player - Competition Matrix (by tier and size of companies)

    15.2. Market Share Analysis, by Company, 2020

    15.3. Company Profiles

        15.3.1. Syneos Health

            15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.1.2. Product Portfolio

            15.3.1.3. SWOT Analysis

            15.3.1.4. Strategic Overview

        15.3.2. PAREXEL International

            15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.2.2. Product Portfolio

            15.3.2.3. SWOT Analysis

            15.3.2.4. Strategic Overview

        15.3.3. ICON plc

            15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.3.2. Product Portfolio

            15.3.3.3. SWOT Analysis

            15.3.3.4. Strategic Overview

        15.3.4. PRA Health Sciences, Inc.

            15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.4.2. Product Portfolio

            15.3.4.3. SWOT Analysis

            15.3.4.4. Strategic Overview

        15.3.5. Charles River

            15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.5.2. Product Portfolio

            15.3.5.3. SWOT Analysis

            15.3.5.4. Strategic Overview

        15.3.6. Laboratory Corporation of America Holdings (Covance)

            15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.6.2. Product Portfolio

            15.3.6.3. SWOT Analysis

            15.3.6.4. Strategic Overview

        15.3.7. IQVIA

            15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.7.2. Product Portfolio

            15.3.7.3. SWOT Analysis

            15.3.7.4. Strategic Overview

        15.3.8. Medpace

            15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.8.2. Product Portfolio

            15.3.8.3. SWOT Analysis

            15.3.8.4. Strategic Overview

        15.3.9. Pharmaceutical Product Development, LLC.

            15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.9.2. Product Portfolio

            15.3.9.3. SWOT Analysis

            15.3.9.4. Strategic Overview

List of Table

Table 01: Global Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Service, 2017–2028

Table 02: Global Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Clinical Trial Services, 2017–2028

Table 03: Global Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Clinical Data Management & Biometrics, 2017–2028

Table 04: Global Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Therapeutic Area, 2017–2028

Table 05: Global Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by End-user, 2017–2028

Table 06: Global Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Region, 2017–2028

Table 07: North America Healthcare Contract Research Outsourcing Market Value (US$ Mn) Forecast, by Country, 2017–2028

Table 08: North America Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Service, 2017–2028

Table 09: North America Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Clinical Trial Service, 2017–2028

Table 10: North America Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Clinical Data Management & Biometrics, 2017–2028

Table 11: North America Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Therapeutic Area, 2017–2028

Table 12: North America Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by End-user, 2017–2028

Table 13: Europe Healthcare Contract Research Outsourcing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2028

Table 14: Europe Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Services, 2017–2028

Table 15: Europe Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Clinical Trial Services, 2017–2028

Table 16: Europe Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Clinical Data management & Biometrics, 2017–2028

Table 17: Europe Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Therapeutic Area, 2017–2028

Table 18: Europe Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by End-user, 2017–2028

Table 19: Asia Pacific Healthcare Contract Research Outsourcing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2028

Table 20: Asia Pacific Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Service, 2017–2028

Table 21: Asia Pacific Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Clinical Trial Services, 2017–2028

Table 22: Asia Pacific Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Clinical Data management & Biometrics, 2017–2028

Table 23: Asia Pacific Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Therapeutic Area, 2017–2028

Table 24: Asia Pacific Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by End-user, 2017–2028

Table 25: Latin America Healthcare Contract Research Outsourcing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2028

Table 26: Latin America Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Service, 2017–2028

Table 27: Latin America Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Clinical Trial Services, 2017–2028

Table 28: Latin America Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Clinical Data management & Biometrics, 2017–2028

Table 29: Latin America Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Therapeutic Area, 2017–2028

Table 30: Latin America Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by End-user, 2017–2028

Table 31: Middle East & Africa Healthcare Contract Research Outsourcing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2028

Table 32: Middle East & Africa Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Service, 2017–2028

Table 33: Middle East & Africa Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Clinical Trial Services, 2017–2028

Table 34: Middle East & Africa Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Clinical Data management & Biometrics, 2017–2028

Table 35: Middle East & Africa Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Therapeutic Area, 2017–2028

Table 36: Middle East & Africa Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by End-user, 2017–2028

List of Figures

Figure 01: Healthcare Contract Research Outsourcing Market Snapshot

Figure 02: Global Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, 2017–2028

Figure 03: Global Healthcare Contract Research Outsourcing Market Value Share, by Therapeutic Area, 2020

Figure 04: Global Healthcare Contract Research Outsourcing Market Value Share, by Region, 2020

Figure 05: Global Healthcare Contract Research Outsourcing Market Value Share, by Service, 2020

Figure 06: Global Healthcare Contract Research Outsourcing Market Value Share, by End-user, 2020

Figure 07: Global Healthcare Contract Research Outsourcing Market Value Share, by Service, 2017 and 2028

Figure 08: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Clinical Trial Services, 2017–2028

Figure 09: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Regulatory Services, 2017–2028

Figure 10: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Clinical Data Management & Biometrics, 2017–2028

Figure 11: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Medical Writing, 2017–2028

Figure 12: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Pharmacovigilance, 2017–2028

Figure 13: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Site Management Protocol, 2017–2028

Figure 14: Global Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Service

Figure 15: Global Healthcare Contract Research Outsourcing Market Value Share, by Therapeutic Area, 2017 and 2028

Figure 16: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Oncology, 2017–2028

Figure 17: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by CNS, 2017–2028

Figure 18: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by CV/Metabolic, 2017–2028

Figure 19: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Respiratory, 2017–2028

Figure 20: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Infectious Diseases, 2017–2028

Figure 21: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Immunology, 2017–2028

Figure 22: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Rare Diseases, 2017–2028

Figure 23: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Medical Devices, 2017–2028

Figure 24: Global Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Therapeutic Area

Figure 25: Global Healthcare Contract Research Outsourcing Market Value Share Analysis, by End-user, 2017 and 2028

Figure 26: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Pharmaceutical Companies, 2017–2028

Figure 27: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Biotechnology Companies, 2017–2028

Figure 28: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Medical Device Companies, 2017–2028

Figure 29: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Academic Institute & Government Organizations Companies, 2017–2028

Figure 30: Global Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by End-user, 2021–2028

Figure 31: Global Healthcare Contract Research Outsourcing Market Value Share Analysis, by Region, 2021 and 2028

Figure 32: Global Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Region, 2021–2028

Figure 33: North America Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, 2017–2028

Figure 34: North America Healthcare Contract Research Outsourcing Market Value Share, by Country, 2020 and 2028

Figure 35: North America Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Country, 2021-2020

Figure 36: North America Healthcare Contract Research Outsourcing Market Value Share, by Services, 2020 and 2028

Figure 37: North America Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Services, 2020-1028

Figure 38: North America Healthcare Contract Research Outsourcing Market Value Share, by Therapeutic Area, 2021-2028

Figure 39: North America Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2021–2028

Figure 40: North America Healthcare Contract Research Outsourcing Market Value Share, by End-user, 2020 and 2028

Figure 41: North America Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by End-user, 2021–2028

Figure 42: Europe Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, 2021–2028

Figure 43: Europe Healthcare Contract Research Outsourcing Market Value Share, by Country/Sub-region, 2020 and 2028

Figure 44: Europe Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Country/Sub-region, 2021–2028

Figure 45: Europe Healthcare Contract Research Outsourcing Market Value Share, by Services, 2020 and 2028

Figure 46: Europe Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Services, 2021–2028

Figure 47: Europe Healthcare Contract Research Outsourcing Market Value Share, by Therapeutic Area, 2020 and 2028

Figure 48: Europe Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2021–2028

Figure 49: Europe Healthcare Contract Research Outsourcing Market Value Share, by End-user, 2020 and 2028

Figure 50: Europe Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by End-user, 2021–2028

Figure 51: Asia Pacific Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, 2017–2028

Figure 52: Asia Pacific Healthcare Contract Research Outsourcing Market Value Share, by Country/Sub-region, 2020 and 2028

Figure 53: Asia Pacific Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Country/Sub-region, 2021-2028

Figure 54: Asia Pacific Healthcare Contract Research Outsourcing Market Value Share, by Service, 2021 and 2028

Figure 55: Asia Pacific Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Service, 2021-2028

Figure 56: Asia Pacific Healthcare Contract Research Outsourcing Market Value Share, by Therapeutic Area, 2021-2028

Figure 57: Asia Pacific Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2021–2028

Figure 58: Asia Pacific Healthcare Contract Research Outsourcing Market Value Share, by End-user, 2020 and 2028

Figure 59: Asia Pacific Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by End-user, 2021–2028

Figure 60: Latin America Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, 2017–2028

Figure 61: Latin America Healthcare Contract Research Outsourcing Market Value Share, by Service, 2020 and 2028

Figure 62: Latin America Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Service, 2021–2028

Figure 63: Latin America Healthcare Contract Research Outsourcing Market Value Share, by Therapeutic Area 2020 and 2028

Figure 64: Latin America Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2021–2028

Figure 65: Latin America Healthcare Contract Research Outsourcing Market Value Share, by End-user, 2020 and 2028

Figure 66: Latin America Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by End-user, 2021–2028

Figure 67: Latin America Healthcare Contract Research Outsourcing Market Value Share, by Country/Sub-region, 2020 and 2028

Figure 68: Latin America Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Country/Sub-region, 2021-2028

Figure 69: Middle East & Africa Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, 2017–2028

Figure 70: Middle East & Africa Healthcare Contract Research Outsourcing Market Value Share, by Country/Sub-region, 2020 and 2028

Figure 71: Middle East & Africa Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Country/Sub-region, 2021-2028

Figure 72: Middle East & Africa Healthcare Contract Research Outsourcing Market Value Share, by Service, 2021 and 2028

Figure 73: Middle East & Africa Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Service, 2021-2028

Figure 74: Middle East & Africa Healthcare Contract Research Outsourcing Market Value Share, by Therapeutic Area, 2021-2028

Figure 75: Middle East & Africa Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2021–2028

Figure 76: Middle East & Africa Healthcare Contract Research Outsourcing Market Value Share, by End-user, 2020 and 2028

Figure 77: Middle East & Africa Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by End-user, 2021–2028

Figure 78: Global Healthcare Contract Research Outsourcing Market Share Analysis, by Company, 2020

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

303

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved